Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of North Carolina, Chapel Hill
University Hospital, Caen
Region Stockholm
Beth Israel Deaconess Medical Center
Assistance Publique - Hôpitaux de Paris
Brain Inflammation Collaborative
University of Pittsburgh
Massachusetts General Hospital
Second Affiliated Hospital of Wenzhou Medical University
Assistance Publique Hopitaux De Marseille
M.D. Anderson Cancer Center
Nordsjaellands Hospital
ProgenaBiome
Takeda
Weill Medical College of Cornell University
Pfizer
Centre Hospitalier Universitaire, Amiens
Janssen Research & Development, LLC